• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

  • Rocky Mountain MS Clinic, Salt Lake City, UT

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 6 - 6 of 6

  • Page:
  • 1
  • 2

Natalizumab Extended Interval Dosing (EID) is Associated with a Reduced Risk of Progressive Multifocal Leukoencephalopathy (PML) Compared with Every-4-Week (Q4W) Dosing: Updated Analysis of the TOUCH® Prescribing Program Database

Author:Zhovtis Ryerson, Lana   Foley, John   Kister, Ilya   Cutter, Gary   Metzger, Ryan   Goldberg, Judith   Li, Xiaochun   Riddle, Evan   Smirnakis, Karen   DSilva, Liesel   Sinks, Susie   Campbell, Nolan   Lasky, Tyler   Bodhinathan, Karthik   

Session Name:P14: MS Clinical Practice  

Topic:MS and Inflammatory Disease  

Program Number:P14.011  

Author Institution:Jersey Shore University Medical Center, Neptune, NJ  Rocky Mountain MS Clinic, Salt Lake City, UT  Department of Neurology, NYU Langone Health, New York University, New York, NY  University of Alabama At Birmingham School of Public Health, Birmingham, AL  New York University Grossman School of Medicine, Division of Biostatistics, New York, NY  Biogen, Cambridge, MA  

  • View Abstract
  • View Disclosure

Displaying 6 - 6 of 6

  • Page:
  • 1
  • 2

© 2015 Mira Smart Conference | http://www.mirasmart.com